2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on IO in Metastatic Melanoma: Is the Addition of Ipilimumab to anti- PD-1 Beneficial in Patients Resistant to PD-1 Monotherapy?

58 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login